# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 139A: Amendment of regulation 179 (obligation on licensing authority to operate pharmacovigilance system)


In regulation 179—
(a) in paragraph (1), after “pharmacovigilance system” insert “in relation to medicinal products for sale or supply in Great Britain”;
(b) after paragraph (1) insert—
“(1A) The licensing authority must operate a pharmacovigilance system in relation to medicinal products for sale or supply in Northern Ireland.”;
(c) in paragraph (2) for “The pharmacovigilance system” substitute “Each pharmacovigilance system”; and
(d) in paragraph (3)(a) for “the pharmacovigilance system” substitute “each pharmacovigilance system”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/139A (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-139A
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.